| Title: |
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial. |
| Authors: |
Merkely, Béla, Hatala, Robert, Wranicz, Jerzy K, Duray, Gábor, Földesi, Csaba, Som, Zoltán, Németh, Marianna, Goscinska-Bis, Kinga, Gellér, László, Zima, Endre, Osztheimer, István, Molnár, Levente, Karády, Júlia, Hindricks, Gerhard, Goldenberg, Ilan, Klein, Helmut, Szigeti, Mátyás, Solomon, Scott D, Kutyifa, Valentina, Kovács, Attila |
| Source: |
European Heart Journal; 10/21/2023, Vol. 44 Issue 40, p4259-4269, 11p |
| Subject Terms: |
CARDIAC pacing, HEART failure, BUNDLE-branch block, IMPLANTABLE cardioverter-defibrillators, MORTALITY, VENTRICULAR ejection fraction |
| Abstract: |
Background and Aims De novo implanted cardiac resynchronization therapy with defibrillator (CRT-D) reduces the risk of morbidity and mortality in patients with left bundle branch block, heart failure and reduced ejection fraction (HFrEF). However, among HFrEF patients with right ventricular pacing (RVP), the efficacy of CRT-D upgrade is uncertain. Methods In this multicentre, randomized, controlled trial, 360 symptomatic (New York Heart Association Classes II–IVa) HFrEF patients with a pacemaker or implantable cardioverter defibrillator (ICD), high RVP burden ≥ 20%, and a wide paced QRS complex duration ≥ 150 ms were randomly assigned to receive CRT-D upgrade (n = 215) or ICD (n = 145) in a 3:2 ratio. The primary outcome was the composite of all-cause mortality, heart failure hospitalization, or <15% reduction of left ventricular end-systolic volume assessed at 12 months. Secondary outcomes included all-cause mortality or heart failure hospitalization. Results Over a median follow-up of 12.4 months, the primary outcome occurred in 58/179 (32.4%) in the CRT-D arm vs. 101/128 (78.9%) in the ICD arm (odds ratio 0.11; 95% confidence interval 0.06–0.19; P <.001). All-cause mortality or heart failure hospitalization occurred in 22/215 (10%) in the CRT-D arm vs. 46/145 (32%) in the ICD arm (hazard ratio 0.27; 95% confidence interval 0.16–0.47; P <.001). The incidence of procedure- or device-related complications was similar between the two arms [CRT-D group 25/211 (12.3%) vs. ICD group 11/142 (7.8%)]. Conclusions In pacemaker or ICD patients with significant RVP burden and reduced ejection fraction, upgrade to CRT-D compared with ICD therapy reduced the combined risk of all-cause mortality, heart failure hospitalization, or absence of reverse remodelling. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Heart Journal is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
